Juvenile Absence Epilepsy Exacerbated by Valproic Acid

Pediatric Neurology

Volumn 36, Issue 2, 2007, Pages 121-124

  Buechler, Robbie D ^a   Buchhalter, Jeffrey R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LORAZEPAM; VALPROIC ACID;

ABSENCE; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; ELECTROENCEPHALOGRAPHY; FEMALE; GRAND MAL SEIZURE; HISTOGRAM; HUMAN; JUVENILE ABSENCE EPILEPSY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SYMPTOM; VIDEOELECTROENCEPHALOGRAPHY;

ANTICONVULSANTS; CHILD; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; SEVERITY OF ILLNESS INDEX; VALPROIC ACID; VIDEO RECORDING;

EID: 33846646070     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2006.08.011     Document Type: Article

References (14)

1. Talwar D., Maninder A., and Sher P. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia 35 (1994) 1154-1159
2. Perucca E., Gram L., Avanzini G., and Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 39 (1998) 5-17
3. Wheless J., Vazquez B., Kanner A., Ramsay R., Morton L., and Pellock J. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology 63 (2004) 1507-1508
4. Chavis J., and Sanders J.W. Seizure aggravation in idiopathic generalized epilepsies. Epilepsia 46 Suppl. 9 (2005) 133-139
5. Hirsh E., and Genton P. Antiepileptic drug-induced pharmacodynamic aggravation of seizures: Does valproate have a lower potential. CNS Drugs 17 (2003) 633-640
6. Lerman-Sagie T., Watemberg N., Kramer U., Shahar E., and Pinchas L. Absence seizures aggravated by valproic acid. Epilepsia 42 (2001) 941-944
7. Sobaniec-Lotowska M. Ultrastructure of astrocytes in the cortex of the hippocampus gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal. Int J Exp Path 84 (2003) 115-125
8. Perucca E. Pharmacological and therapeutic properties of a valproate: A summary after 35 years of clinical experience. CNS Drugs 16 (2002) 695-714
9. So E., Ruggles K., Cascino G., Ahmann P., and Weatherford K. Seizure exacerbation and status epilepticus related to carbamazepine-10, 11 epoxide. Ann Neurol 35 (1994) 743-746
10. Genton P., and McMenamin J. Can epileptic drugs aggravate epilepsy?. Epilepsia 39 (1998) 1-26
11. Sannita W. Valproate acute administration, EEG epileptic abnormalities, and ammonemia. Neurology 42 (1992) 2003-2005
12. Zaccara G., Paganini M., Campostrini R., Arnetoli G., Zappoli R., and Moroni F. Hyperammonemia and valproate-induced alterations of the state of consciousness. Eur Neurol 23 (1984) 104-112
13. Mireles R., and Leppik I. Valproate and clonazepam comedication in patients with intractable epilepsy. Epilepsia 26 (1985) 122-126
14. Gaita F., Giustetto C., and Riccardi R. Wolff-Parkinson-White syndrome: Identification and management. Drugs 43 (1992) 185-200